Oncosil Medical Ltd has released a press release.
Australian Manufacturing Facility Achieves ISO 13485
Earlier from Oncosil Medical
- OSL Secures $5.6 million from Major Institutional Investors
- OncoSil Receives FDA Approval for Distal Cholangiocarcinoma
- OncoSil Medical Completes Manufacturing Validation
- OncoSil Medical Files for FDA Approval